rethinkTHC Search
Menu
Study breakdown

THCV Can Either Mimic or Block THC Effects in Rats Depending on Dose

Animal StudyLow evidence
The takeaway

In a rat drug discrimination model, THCV partially mimicked THC at moderate doses but blocked THC effects at higher doses, suggesting it acts as a partial CB1 agonist with dose-dependent switching.

Cannabis researchers, product formulators, pharmacologists

THCV can mimic or block THC depending on dose

What the researchers found

THCV produced an inverted U-shaped response curve in THC-trained rats. At 3 mg/kg, it partially substituted for THC (54.6%). At 6 mg/kg, it reversed THC-induced responding. Blood THC levels were unchanged when combined with THCV, confirming the interaction is pharmacological rather than pharmacokinetic.

Why it matters

THCV is increasingly marketed as a distinct cannabinoid, but its pharmacology is complex. This study demonstrates it can act like THC or oppose THC depending on dose, which has real implications for consumers and product formulators.

The numbers in context

16 rats; THCV at 3 mg/kg partially substituted for THC at 54.6%; THCV at 6 mg/kg reversed THC (0.75 mg/kg) responding (p = 0.040); blood THC/11-OH-THC levels unchanged by THCV co-administration.

How the study worked

Drug discrimination study in 16 male Sprague-Dawley rats trained to distinguish THC (3 mg/kg) from vehicle under a fixed ratio 20 schedule. Tested THCV alone and in combination with THC, with blood cannabinoid level measurements.

What this study cannot tell us

Animal study using only male rats, limiting generalizability to humans and across sexes. Drug discrimination is a behavioral proxy, not a direct measure of subjective effects. Dose ranges may not translate directly to human consumption.

How to read the evidence

Well-designed animal drug discrimination study, but findings require human confirmation.

When this study was published

2025 publication

The bigger picture

As cannabis products increasingly feature specific cannabinoid profiles, understanding how minor cannabinoids like THCV interact with THC is critical. A compound that can both mimic and block THC depending on dose challenges simple marketing claims about THCV effects.

Questions still open

  • At what doses does THCV switch from THC-like to THC-blocking effects in humans?
  • How does THCV interact with THC in actual cannabis products at typical consumption levels?

Common questions

What does THCV do compared to THC?
In this rat study, THCV showed dose-dependent dual effects: at moderate doses it partially mimicked THC (54.6% substitution), but at higher doses it blocked THC effects. This suggests THCV acts as a partial CB1 agonist.
Does THCV change how the body processes THC?
No. Blood levels of THC and its metabolite 11-OH-THC were unchanged when THCV was co-administered, meaning the interaction between the two cannabinoids is pharmacological (at the receptor level) rather than metabolic.

Read the original research

Tetrahydrocannabivarin (THCV) Dose Dependently Blocks or Substitutes for Tetrahydrocannabinol (THC) in a Drug Discrimination Task in Rats.

Biomolecules, 15(9)

Citation

Kayir, Hakan; Kouroukis, Larissa; Aziz, Iman; Khokhar, Jibran Younis. (2025). Tetrahydrocannabivarin (THCV) Dose Dependently Blocks or Substitutes for Tetrahydrocannabinol (THC) in a Drug Discrimination Task in Rats.. Biomolecules, 15(9). https://doi.org/10.3390/biom15091329

Explore the wider topic